tiprankstipranks
Trending News
More News >
Horizon Technology (HRZN)
NASDAQ:HRZN
US Market

Horizon Technology (HRZN) AI Stock Analysis

Compare
1,522 Followers

Top Page

HRZN

Horizon Technology

(NASDAQ:HRZN)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
$4.50
â–²(9.76% Upside)
Action:ReiteratedDate:03/19/26
The score is driven primarily by improved 2025 financial performance and supportive earnings-call outlook tied to scaling and distribution coverage post-merger. These positives are offset by weak technicals (clear downtrend and bearish momentum) and ongoing concerns around NAV/NII pressure and leverage/financial comparability, despite attractive valuation and yield.
Positive Factors
High portfolio yields
Consistently high portfolio yields (14.3% Q4, ~16% FY2025) create a durable spread over funding costs for a BDC. That margin supports recurring net investment income, helps cover distributions, and provides a cushion to absorb credit losses or modest yield compression over months.
Strong liquidity & capacity
Large available liquidity and ~ $472M potential investment capacity give Horizon the durable ability to originate and hold loans, support follow-ons, and deploy into attractive yields without immediate costly capital raises. This enhances origination optionality and risk management over 2–6 months.
Strategic JV expands origination
The $100M joint venture with CRFH structurally broadens Horizon's addressable market into underserved small/micro-cap public companies. Shared governance and Monroe support can sustainably expand deal flow, diversify origination channels, and add fee/interest income over the medium term.
Negative Factors
Material NAV decline
A ~17% YoY NAV decline signals material unrealized markdowns that reduce the shareholder capital cushion. Persistent NAV erosion constrains the company’s ability to raise equity, pressures distribution sustainability, and indicates that marked-to-market exits have impaired long-term value accrual for investors.
Earnings & cashflow volatility
The company’s earnings and cashflow history has swung materially across cycles, undermining predictability of NII and free cash generation. Such volatility complicates reliable distribution coverage, capital planning, and investor confidence, increasing reliance on nonrecurring fees or equity gains.
Leverage & comparability uncertainty
An abrupt report of zero total debt in 2025 after ~$468M in 2024 creates comparability and leverage ambiguity. This obscures the true funding mix and financial risk profile, making it harder to assess durable coverage of distributions and sensitivity to funding-cost shifts during integration.

Horizon Technology (HRZN) vs. SPDR S&P 500 ETF (SPY)

Horizon Technology Business Overview & Revenue Model

Company DescriptionHorizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. It seeks to invest in companies in the United States.
How the Company Makes MoneyHRZN makes money primarily by earning interest income and related fees from its investment portfolio of loans and other debt instruments made to its portfolio companies. Key revenue streams include: (1) recurring cash interest collected on outstanding principal balances, generally based on contracted coupon rates; (2) upfront fees and other loan origination-related charges (such as structuring or closing fees) that are recognized as investment income over the life of the loan under applicable accounting treatment; (3) prepayment, amendment, and other transactional fees earned when borrowers refinance, repay early, or modify loan terms; and (4) gains (or losses) from equity-related positions received in connection with lending, such as warrants or other equity interests, which can produce income through realized gains upon sale/exit and changes in fair value. As a BDC, HRZN’s earnings capacity is influenced by factors such as portfolio size, yields on new and existing loans, credit performance (including non-accruals), leverage/funding costs (the spread between asset yields and borrowing costs), and the pace of repayments and new originations. Specific details about individual borrower relationships, contractual terms, or named partnerships are null.

Horizon Technology Earnings Call Summary

Earnings Call Date:Mar 03, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 05, 2026
Earnings Call Sentiment Neutral
The call conveyed a mix of solid operational progress and strategic positioning alongside near-term earnings and NAV pressure. Highlights include industry-leading yields, portfolio growth in Q4, strong liquidity and capital capacity, an improving committed backlog, and a transformational merger expected to expand scale and origination capabilities. Lowlights included a meaningful QoQ and YoY NAV decline, lower Q4 NII per share driven by reduced prepayment income and timing of fundings, modest yield compression, and no incentive fees recognized in the quarter. Overall, the company appears well positioned for growth post-merger but is managing short-term earnings/NAV headwinds.
Q4-2025 Updates
Positive Updates
Strong Debt Portfolio Yields
Debt portfolio yield of 14.3% in Q4 2025 and nearly 16% for full-year 2025, positioning the company among the highest-yielding BDC debt portfolios and supporting future NII generation.
Return to Portfolio Growth and Originations
Total investment portfolio ended the year at $647,000,000. Q4 fundings included nine debt investments totaling $103,000,000, and the company had a committed and approved backlog of $154,000,000 (up $35,000,000 from Q3, a ~29.4% increase).
Robust Liquidity and Capital Capacity
Available liquidity of $189,000,000 (including $143,000,000 cash) and potential new investment capacity of $472,000,000 as of December 31, 2025; debt-to-equity ratio 1.5x and net leverage 1.05x (below target).
Strategic Capital Markets Activity
Raised $57,500,000 via 7% notes due 2028 and $40,000,000 of 5.5% convertible notes due 2030 in 2025; redeemed 2026 public notes in January 2026 using proceeds; opportunistic ATM program raised over $14,000,000.
Merger with MRCC Expected to Expand Scale
Merger delayed into 2026 but special meeting scheduled; closing expected to materially increase capital available for investing, enable larger co-investments with Monroe Capital, and provide economies of scale to originate larger venture loans.
Strong Venture Equity Upside Exposure
Held warrants, equity, and other investments in 97 portfolio companies with fair value of $51,000,000, reflecting structured deals that can generate upside beyond interest income.
Improvement in Asset Quality and Nonaccruals
Aggregate nonaccruals declined quarter-over-quarter from four to three companies; management reported continued active work to optimize recoveries and improve credit quality.
Negative Updates
Decline in Net Asset Value (NAV)
NAV per share decreased to $6.98 as of 12/31/2025 from $7.12 at 09/30/2025 (down ~$0.14, ~-2.0% QoQ) and from $8.43 at 12/31/2024 (down ~$1.45, ~-17.2% YoY), driven primarily by distributions exceeding NII for the quarter.
Lower Q4 Net Investment Income per Share
Net investment income (NII) per share for Q4 2025 was $0.18, down from $0.32 in Q4 2024 (a ~-43.8% decline YoY) and below prior-year levels, reflecting timing of fundings and lower prepayment-related income.
Slight Compression in Portfolio and Onboarding Yields
Quarterly loan portfolio yield was 14.3% in Q4 2025 versus 14.9% in Q4 2024 (a -0.6 percentage point change, ~-4.0% relative). Onboarding yield was 12.0% in 2025 versus 12.2% in 2024 (a -0.2 ppt change).
Lower Prepayment Activity Reduced Fee Income
Prepayment activity was lower than historical norms in Q4, with prepaid principal and refinancings/partial paydowns totaling approximately $50,000,000 during the quarter/year period, which reduced the typically associated prepayment income and contributed to lower NII.
No Incentive Fees Recognized in Q4
The advisor received no performance-based incentive fees in Q4 due to the incentive fee cap deferral mechanism; while the advisor agreed to waive up to $4,000,000 of fees contingent on merger completion, deferral reflects pressure on earnings recognition in the period.
Realized Losses and Limited Disclosure on Some Exits
There were realized losses recognized in the quarter (small positions such as TALIC contributed), although net realized and unrealized gains were slightly positive overall; management provided limited specifics due to portfolio confidentiality.
Market/Exit Conditions Mixed for Some Subsectors
Life science IPO market remains limited, and while exit markets are open but slow; some second-half 2025 IPO performance may make bankers/investors circumspect in 2026, which can affect exit timing and valuation upside for certain portfolio companies.
Company Guidance
Management guided that, with the anticipated MRCC merger and Monroe co-investment support, Horizon expects to scale into larger venture loans and grow its portfolio and net investment income (NII) over time—with a goal that NII covers or exceeds the declared monthly distribution of $0.06 per share for April–June 2026. Key metrics cited: Q4 NII $0.18/share and FY2025 NII $1.50/share; NAV $6.98 and undistributed spillover $0.65/share; year-end portfolio $647M (debt portfolio yield 14.3% Q4, ~16% FY2025; onboarding yield 12%); Q4 originations $103M and committed backlog $154M; warrants/equity fair value $51M across 97 companies; available liquidity $189M (cash $143M + $46M undrawn), debt-to-equity 1.5x, net leverage 1.05x, and potential new investment capacity ~$472M—all cited as supporting expected growth and continued high yields in the venture debt market.

Horizon Technology Financial Statement Overview

Summary
Financials improved meaningfully in 2025 with a sharp rebound in revenue and profitability and stronger recent free cash flow. However, results have been volatile across the cycle, and comparability is clouded by the abrupt shift to zero reported debt in 2025 after several years of elevated leverage.
Income Statement
62
Positive
Results show a sharp turnaround in 2025: revenue surged to $96.0M (up ~420% year-over-year) and net income rebounded to $45.5M with a strong ~47% net margin, lifting profitability meaningfully versus losses in 2023–2024. However, the earnings profile has been volatile over the cycle (profitable in 2020–2022, then losses in 2023–2024, then a rebound in 2025), which lowers confidence in durability. Several operating profitability line items are reported as zero in 2025, limiting visibility into the quality of the rebound across the income statement.
Balance Sheet
55
Neutral
The balance sheet shows a sizable equity base (~$318.5M in 2025) against ~$811.1M of assets, and return on equity improved to ~14% in 2025 after being negative in 2023–2024. That said, leverage was elevated in prior years (debt-to-equity ~1.36–1.43 during 2022–2024), indicating meaningful balance-sheet risk through the downturn. 2025 reports total debt as zero, which is a dramatic change from ~ $468M in 2024; without additional context, this creates uncertainty about comparability and the true leverage trajectory.
Cash Flow
68
Positive
Cash generation improved: operating cash flow and free cash flow were positive in 2023–2025 (about $50.1M, $39.6M, and $56.6M respectively), with free cash flow up ~36% in 2025. Cash flow also held up better than earnings during weaker periods, helping reduce downside risk. The main weakness is historical volatility—2020–2022 show materially negative operating and free cash flow (including a very large outflow in 2022), suggesting cash conversion can swing significantly depending on period conditions.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue40.91M33.94M19.10M45.84M45.30M
Gross Profit27.64M1.69M-9.87M26.64M33.27M
EBITDA30.14M-4.16M-15.70M21.87M28.18M
Net Income45.48M-5.63M-17.18M21.15M27.78M
Balance Sheet
Total Assets811.10M821.83M802.36M766.83M513.96M
Cash, Cash Equivalents and Short-Term Investments105.52M70.26M46.63M20.61M38.05M
Total Debt473.03M467.90M462.24M434.08M257.61M
Total Liabilities492.60M485.65M478.38M448.38M268.63M
Stockholders Equity318.50M336.18M323.98M318.45M245.34M
Cash Flow
Free Cash Flow56.63M39.64M50.07M-246.28M-75.99M
Operating Cash Flow56.63M39.64M50.07M-246.28M-75.99M
Investing Cash Flow16.67M-35.70M-55.33M-372.01M-291.49M
Financing Cash Flow-14.80M21.21M50.51M229.46M75.52M

Horizon Technology Technical Analysis

Technical Analysis Sentiment
Negative
Last Price4.10
Price Trends
50DMA
5.80
Negative
100DMA
5.97
Negative
200DMA
6.10
Negative
Market Momentum
MACD
-0.54
Positive
RSI
25.28
Positive
STOCH
48.91
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HRZN, the sentiment is Negative. The current price of 4.1 is below the 20-day moving average (MA) of 4.89, below the 50-day MA of 5.80, and below the 200-day MA of 6.10, indicating a bearish trend. The MACD of -0.54 indicates Positive momentum. The RSI at 25.28 is Positive, neither overbought nor oversold. The STOCH value of 48.91 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HRZN.

Horizon Technology Risk Analysis

Horizon Technology disclosed 113 risk factors in its most recent earnings report. Horizon Technology reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Horizon Technology Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
62
Neutral
$2.60B10.0115.88%10.00%-15.32%-12.29%
61
Neutral
―7.73-0.87%20.92%-11.22%-433.61%
59
Neutral
$295.14M10.645.42%16.61%-3.09%200.66%
55
Neutral
$265.16M13.300.03%12.83%90.34%-44.25%
53
Neutral
$296.00M-5.23-12.44%21.13%-91.81%78.46%
52
Neutral
$198.81M8.1414.02%17.28%206.13%298.86%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HRZN
Horizon Technology
4.10
-3.47
-45.83%
HTGC
Hercules Capital, Inc.
14.17
-3.15
-18.18%
PNNT
Pennantpark Investment
4.52
-1.57
-25.83%
SCM
Stellus Capital
9.16
-3.48
-27.55%
TCPC
BlackRock TCP Capital
3.51
-3.11
-46.95%
TPVG
TriplePoint Venture Growth
4.91
-1.16
-19.08%

Horizon Technology Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Horizon Technology Forms $100 Million Growth Capital Venture
Positive
Mar 19, 2026

On March 18, 2026, Horizon Technology Finance Corporation and CR Financial Holdings entered into an LLC agreement to co-manage HRZN CRFH LLC, a new joint venture capitalized with up to $100 million, of which Horizon will provide up to $87.5 million and CRFH up to $12.5 million. Governance will be shared via a board and investment committee with equal representation, requiring unanimous approval for investments and majority approval for other management decisions.

Announced publicly on March 19, 2026, the joint venture will provide growth capital financing solutions, primarily secured loans in the $5–25 million range, to small- and micro-cap public companies in the U.S., with the ability to upsize deals supported by Monroe Capital’s larger capital base. The initiative broadens Horizon’s lending reach in an underserved multi-billion-dollar market segment, aligns with its strategy to scale support for innovative high-growth companies, and offers CRFH an expanded platform to deliver debt capital solutions to publicly traded clients, potentially enhancing value for both firms’ stakeholders.

The most recent analyst rating on (HRZN) stock is a Buy with a $4.50 price target. To see the full list of analyst forecasts on Horizon Technology stock, see the HRZN Stock Forecast page.

Business Operations and StrategyM&A TransactionsShareholder Meetings
Horizon Technology Shareholders Approve Monroe Capital Merger Deal
Positive
Mar 16, 2026

On March 16, 2026, Horizon Technology Finance Corporation and Monroe Capital Corporation reported that their respective shareholders overwhelmingly approved key proposals at special meetings held on March 13, 2026, clearing the way for Monroe Capital Corporation to sell substantially all of its assets for cash to Monroe Capital Income Plus Corporation and then merge into Horizon. Horizon will remain the surviving NASDAQ‑listed entity under the HRZN ticker, continue under existing external management, and use an exchange ratio based on relative net asset values, while Monroe shareholders are set to receive a pre‑merger cash distribution of about $0.75 per share, and Horizon’s adviser has agreed to waive up to $4 million of fees over four quarters to support the combined company’s earnings profile and scale in venture lending.

The transactions, which are still subject to customary closing conditions and expected to close within about 30 days of the announcement, aim to unlock value at Monroe while bolstering Horizon’s growth capital, enhancing its earnings potential and cost efficiencies, and reinforcing its positioning as a leading financing partner to high‑growth, venture‑backed companies. MRCC’s final tax distribution is designed to preserve its regulated investment company status, its dividend reinvestment plan will not apply to that payout, and Horizon’s board has signaled plans to tap undistributed taxable earnings to supplement post‑merger shareholder distributions for two quarters, underscoring a focus on shareholder returns during the integration phase.

The most recent analyst rating on (HRZN) stock is a Buy with a $4.50 price target. To see the full list of analyst forecasts on Horizon Technology stock, see the HRZN Stock Forecast page.

Executive/Board ChangesM&A TransactionsShareholder Meetings
Horizon Technology Shareholders Approve Merger-Related Share Issuance
Positive
Mar 13, 2026

On March 13, 2026, Horizon Technology Finance Corporation held a special meeting of stockholders at which investors approved the issuance of new common shares pursuant to a previously announced merger agreement, with 19,318,369 votes in favor, 3,776,878 against, and 1,755,735 abstentions. At the same meeting, stockholders also elected Thomas J. Allison as a Class I director to serve until the 2026 annual meeting, with 20,996,897 votes for and 3,854,085 withheld, an appointment that will take effect only upon the closing of the merger, underscoring shareholder support for the company’s planned combination and related board changes.

The most recent analyst rating on (HRZN) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on Horizon Technology stock, see the HRZN Stock Forecast page.

Legal ProceedingsM&A TransactionsShareholder Meetings
Horizon Technology Addresses Lawsuits Over Monroe Merger Disclosures
Negative
Mar 6, 2026

On August 7, 2025, Horizon Technology Finance agreed to a two-step merger with Monroe Capital Corporation, following Monroe’s sale of its investment assets to Monroe Capital Income Plus Corporation for cash, in a deal that would ultimately make Monroe a wholly owned subsidiary before being folded into Horizon. On January 30, 2026, class action claims were filed in Delaware and New York alleging the joint proxy statement for the transaction contained misleading and incomplete disclosures, prompting Horizon, while denying any wrongdoing and maintaining the complaints are without merit, to voluntarily issue supplemental proxy disclosures that do not alter merger consideration or the scheduled March 13, 2026 shareholder vote, as its independent board committee continues to unanimously urge investors to back the merger-related proposals.

The legal challenges to Horizon’s merger with Monroe focus on alleged disclosure deficiencies that plaintiffs argue should delay or block the deal, but Horizon’s decision to supplement the proxy without changing deal terms suggests a strategy to minimize litigation risk while keeping the transaction on track. For shareholders and other stakeholders, the outcome of these suits and the March 13, 2026 special meeting will be pivotal for determining Horizon’s future scale in the specialty finance market and the ultimate structure of its combined portfolio and governance.

The most recent analyst rating on (HRZN) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on Horizon Technology stock, see the HRZN Stock Forecast page.

Business Operations and StrategyDividendsM&A Transactions
Horizon Technology Declares Q2 2026 Monthly Cash Distributions
Positive
Mar 4, 2026

On March 3, 2026, Horizon Technology Finance said its board approved monthly cash distributions of $0.06 per share for each of April, May and June 2026, for a total of $0.18 per share, with ex‑dividend and record dates on March 16, April 16 and May 18 and corresponding payment dates on April 15, May 15 and June 16. The business development company noted it has paid $360 million in cumulative shareholder distributions since its 2010 IPO, and said the latest payout levels were set after reviewing taxable income, spillover income and its longer‑term outlook, including the expected impact of its planned merger with Monroe Capital Corporation and the operation of its dividend reinvestment plan, which allows most investors to receive shares instead of cash.

Horizon’s board explained that distribution decisions reflect differences between taxable income and GAAP net income, driven by unrealized gains or losses and timing differences in income and expense recognition. The company also highlighted its dividend reinvestment plan mechanics, under which it can issue new shares or repurchase stock in the open market to satisfy reinvestment demand, a structure that may modestly support capital levels and liquidity while maintaining regular income for shareholders as it moves toward combining with Monroe Capital Corporation.

The most recent analyst rating on (HRZN) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Horizon Technology stock, see the HRZN Stock Forecast page.

Business Operations and StrategyPrivate Placements and Financing
Horizon Technology Updates Key Financing and Servicing Agreements
Positive
Feb 11, 2026

On February 6, 2026, Horizon Credit II LLC, a wholly owned subsidiary of Horizon Technology Finance Corporation, amended its existing loan and security agreement with a syndicate of lenders arranged and led by KeyBank National Association, updating the terms of a facility originally restated in June 2021. On February 10, 2026, the subsidiary and its parent also amended their sale and servicing agreement with Horizon Technology Finance Management LLC, U.S. Bank National Association, and KeyBank, refining the operational framework that governs loan purchases, servicing, and collateral management within the company’s financing structure.

These coordinated amendments signal an ongoing optimization of Horizon Technology Finance’s funding and servicing arrangements, which may enhance the efficiency and resilience of its credit platform and strengthen relationships with key banking partners and service providers. While the company did not disclose specific revised terms, the moves underscore active management of its capital structure and operational agreements in support of its specialty lending activities.

The most recent analyst rating on (HRZN) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Horizon Technology stock, see the HRZN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026